Published in Am J Physiol Heart Circ Physiol on October 05, 2007
Muscle afferent feedback during exercise: putting the pressure on flow. J Physiol (2011) 0.75
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol (2009) 5.31
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med (2002) 3.91
Inhaled iloprost for severe pulmonary hypertension. N Engl J Med (2002) 3.90
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J (2004) 3.51
Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med (2006) 3.14
Validity of pulse pressure and augmentation index as surrogate measures of arterial stiffness during beta-adrenergic stimulation. J Hypertens (2004) 2.74
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol (2006) 2.42
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension. Eur Respir J (2012) 2.32
Acute effects of passive smoking on peripheral vascular function. Hypertension (2008) 2.25
ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens (2012) 2.24
Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med (2014) 2.14
Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension. Am J Physiol Heart Circ Physiol (2013) 2.07
Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol (2005) 1.82
Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation (2004) 1.79
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol (2009) 1.78
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol (2002) 1.77
Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation (2003) 1.71
Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure. Crit Care Med (2004) 1.71
Assessment and prognostic relevance of right ventricular contractile reserve in patients with severe pulmonary hypertension. Circulation (2013) 1.62
Exercise pathophysiology in patients with chronic mountain sickness exercise in chronic mountain sickness. Chest (2012) 1.59
Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol (2003) 1.58
Reduction of left ventricular diameter and mass after surgical arteriovenous fistula closure in renal transplant recipients. Transplantation (2002) 1.55
Pulmonary circulation and gas exchange at exercise in Sherpas at high altitude. J Appl Physiol (1985) (2013) 1.55
Sympathetic control after cardiac resynchronization therapy: responders versus nonresponders. Am J Physiol Heart Circ Physiol (2006) 1.50
Atorvastatin reduces sympathetic activity and increases baroreceptor reflex sensitivity in patients with hypercholesterolaemia and systemic arterial hypertension. Kardiol Pol (2009) 1.48
Beta-adrenergic blockade and metabo-chemoreflex contributions to exercise capacity. Med Sci Sports Exerc (2008) 1.46
Activation of apoptotic pathways in experimental acute afterload-induced right ventricular failure. Crit Care Med (2010) 1.45
Sympathoexcitation increases the QT/RR slope in healthy men: differential effects of hypoxia, dobutamine, and phenylephrine. J Cardiovasc Electrophysiol (2007) 1.43
Acute pulmonary embolism: relationships between ground-glass opacification at thin-section CT and hemodynamics in pigs. Radiology (2009) 1.42
Echocardiography of pulmonary vascular function in asymptomatic carriers of BMPR2 mutations. Eur Respir J (2012) 1.41
Dobutamine stress echocardiography for the assessment of pressure-flow relationships of the pulmonary circulation. Chest (2014) 1.40
Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation (2013) 1.35
Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr (2012) 1.33
Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension. Am J Respir Crit Care Med (2006) 1.29
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies. Br J Haematol (2010) 1.25
Endothelin receptor antagonists. Pharmacol Ther (2005) 1.24
Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol (2004) 1.24
Pulmonary vascular distensibility predicts aerobic capacity in healthy individuals. J Physiol (2012) 1.20
Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. Chest (2014) 1.20
Proximal pulmonary arterial obstruction decreases the time constant of the pulmonary circulation and increases right ventricular afterload. J Appl Physiol (1985) (2013) 1.19
Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med (2010) 1.19
Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials. J Heart Lung Transplant (2011) 1.16
Tissue Doppler imaging evaluation of cardiac adaptation to severe pulmonary hypertension. Am J Cardiol (2007) 1.15
Right ventricular adaptation to pulmonary hypertension: an interspecies comparison. Am J Physiol Heart Circ Physiol (2003) 1.13
Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension. Chest (2006) 1.13
Causal relationships between heart period and systolic arterial pressure during graded head-up tilt. Am J Physiol Regul Integr Comp Physiol (2010) 1.09
Preoperative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Circulation (2003) 1.08
Measurement to predict survival: the case of diastolic pulmonary gradient. JACC Heart Fail (2015) 1.07
Exercise stress echocardiography of the pulmonary circulation: limits of normal and sex differences. Chest (2012) 1.05
Ethnic differences in arterial stiffness and wave reflections after cigarette smoking. J Hypertens (2006) 1.04
Tonic activity of carotid body chemoreceptors contributes to the increased sympathetic drive in essential hypertension. Hypertens Res (2011) 1.04
Transitioning from i.v. epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension. Chest (2002) 1.03
Acute arterio-venous fistula occlusion decreases sympathetic activity and improves baroreflex control in kidney transplanted patients. Nephrol Dial Transplant (2004) 1.03
Feasibility of routine pulmonary arterial impedance measurements in pulmonary hypertension. Chest (2004) 1.03
Importance of hypoxic vasoconstriction in maintaining oxygenation during acute lung injury. Crit Care Med (2002) 1.01
Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension. Br J Clin Pharmacol (2011) 1.00
Pulmonary arterial pulse pressure and mortality in pulmonary arterial hypertension. Respir Med (2007) 0.99
Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension. Int J Cardiol (2013) 0.99
Arteriovenous fistula closure after renal transplantation: a prospective study with 24-hour ambulatory blood pressure monitoring. Transplantation (2008) 0.98
Effects of high altitude exposure on cerebral hemodynamics in normal subjects. Stroke (2005) 0.98
Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure. Eur Heart J (2011) 0.97
Right and left ventricular adaptation to hypoxia: a tissue Doppler imaging study. Am J Physiol Heart Circ Physiol (2005) 0.97
How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Respir Crit Care Med (2007) 0.97
Contemporary outcomes of supraventricular tachycardia ablation in congenital heart disease: a single-center experience in 116 patients. Circ Arrhythm Electrophysiol (2013) 0.96
Acute cardiovascular and sympathetic effects of nicotine replacement therapy. Hypertension (2006) 0.96
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. Am Heart J (2002) 0.96
Respiratory-related heart rate variability in progressive experimental heart failure. Am J Physiol Heart Circ Physiol (2005) 0.96
Impedance in isolated mouse lungs for the determination of site of action of vasoactive agents and disease. Ann Biomed Eng (2010) 0.96
Regression of left ventricular hypertrophy after arteriovenous fistula closure in renal transplant recipients: a long-term follow-up. Am J Transplant (2004) 0.95
Environmental determinants of blood pressure, arterial stiffness, and central hemodynamics. J Hypertens (2010) 0.95
Echocardiographic and tissue Doppler imaging of cardiac adaptation to high altitude in native highlanders versus acclimatized lowlanders. Am J Cardiol (2009) 0.94
Sympathetic neural outflow and chemoreflex sensitivity are related to spontaneous breathing rate in normal men. Hypertension (2005) 0.94
Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction. J Thorac Cardiovasc Surg (2009) 0.94
Circulating apoptotic endothelial cells and apoptotic endothelial microparticles independently predict the presence of cardiac allograft vasculopathy. J Am Coll Cardiol (2012) 0.94
Interdependency between heart rate variability and sleep EEG: linear/non-linear? Clin Neurophysiol (2004) 0.93
Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension. Eur Respir J (2012) 0.92
Nicotine increases chemoreflex sensitivity to hypoxia in non-smokers. J Hypertens (2008) 0.92
Elevated prevalence of arterial hypertension amongst Belgian taxi drivers during the World Hypertension Day campaign 2006. J Hypertens (2006) 0.92
Early activation of cardiac and renal endothelin systems in experimental heart failure. Am J Physiol Heart Circ Physiol (2003) 0.91
Acute exposure to diesel exhaust impairs nitric oxide-mediated endothelial vasomotor function by increasing endothelial oxidative stress. Hypertension (2013) 0.91
Elevated prevalence of arterial hypertension in the Belgian parliament. J Hypertens (2005) 0.91
Hyperoxia enhances metaboreflex sensitivity during static exercise in humans. Am J Physiol Heart Circ Physiol (2006) 0.91
Activin-A, transforming growth factor-beta, and myostatin signaling pathway in experimental dilated cardiomyopathy. J Card Fail (2008) 0.91
Lung membrane conductance and capillary volume derived from the NO and CO transfer in high-altitude newcomers. J Appl Physiol (1985) (2013) 0.91
Arterial stiffness and wave reflections in patients with sickle cell disease. Hypertension (2004) 0.90